Euclises Pharmaceuticals, Inc. announced it raised $0 in an initial filing from an offering of $663,000

Oct 01, 2015•about 10 years ago

Amount Raised

MissouriHealthcare

Company Information

Company

Euclises Pharmaceuticals, Inc.

Location

Missouri, United States

About

Euclises Pharmaceuticals develops novel COX-2 inhibitors for the effective treatment of cancers in the lungs, colon, and pancreas.